155 related articles for article (PubMed ID: 31410964)
1. Nomenclature of factor XI and the contact system.
Schmaier AH; Emsley J; Feener EP; Gailani D; Govers-Riemslag JWP; Kaplan AP; Maas C; Morrissey JH; Renné T; Sidelmann JJ; Meijers JCM
J Thromb Haemost; 2019 Dec; 17(12):2216-2219. PubMed ID: 31410964
[No Abstract] [Full Text] [Related]
2. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
Renné T; Gailani D; Meijers JC; Müller-Esterl W
J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
[TBL] [Abstract][Full Text] [Related]
3. Surface activation of blood coagulation, fibrinolysis and kinin formation.
Heimark RL; Kurachi K; Fujikawa K; Davie EW
Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
Griffin JH; Cochrane CG
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
[TBL] [Abstract][Full Text] [Related]
5. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
Silverberg M; Nicoll JE; Kaplan AP
Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319
[No Abstract] [Full Text] [Related]
6. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
[TBL] [Abstract][Full Text] [Related]
7. Factor XII in coagulation, inflammation and beyond.
Didiasova M; Wujak L; Schaefer L; Wygrecka M
Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
Hooley E; McEwan PA; Emsley J
J Thromb Haemost; 2007 Dec; 5(12):2461-6. PubMed ID: 17922805
[TBL] [Abstract][Full Text] [Related]
9. The bradykinin-forming cascade: a historical perspective.
Kaplan AP
Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
[TBL] [Abstract][Full Text] [Related]
10. [Initiation mechanism of intrinsic blood coagulation: activation of factor XII and roles of high-molecular-weight kininogen (author's transl)].
Kato H
Seikagaku; 1980 Nov; 52(11):1173-200. PubMed ID: 7021705
[No Abstract] [Full Text] [Related]
11. [Protein and gene structures of the contact factors and their abnormalities].
Fujikawa K; Asakai R
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):976-83. PubMed ID: 3270916
[No Abstract] [Full Text] [Related]
12. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
[TBL] [Abstract][Full Text] [Related]
13. The contact activation proteins: a structure/function overview.
Meijers JC; McMullen BA; Bouma BN
Agents Actions Suppl; 1992; 38 ( Pt 2)():219-30. PubMed ID: 1462829
[TBL] [Abstract][Full Text] [Related]
14. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
[TBL] [Abstract][Full Text] [Related]
15. Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo.
Chen ZL; Singh PK; Horn K; Calvano MR; Kaneki S; McCrae KR; Strickland S; Norris EH
Blood Adv; 2023 Apr; 7(7):1156-1167. PubMed ID: 36409609
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
Kaplan AP; Silverberg M; Dunn JT; Miller G
Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
[TBL] [Abstract][Full Text] [Related]
17. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
Wiggins RC; Cochrane CG; Griffin JH
Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
[No Abstract] [Full Text] [Related]
18. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
[TBL] [Abstract][Full Text] [Related]
19. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.
Revak SD; Cochrane CG; Bouma BN; Griffin JH
J Exp Med; 1978 Mar; 147(3):719-29. PubMed ID: 632748
[TBL] [Abstract][Full Text] [Related]
20. [The so-called "contact" system of plasma: consequences of the activation of the Hageman factor].
Damas J; Adam A
Ann Biol Clin (Paris); 1988; 46(3):185-9. PubMed ID: 3044204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
